D-0895-2023 Class II Terminated
FDA drug recall D-0895-2023 was initiated by Strides Pharma Inc. on Jun 26, 2023 and is designated Class II. Reason for recall: Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet. The recall status is terminated (terminated May 15, 2024). Affected quantity: 2,700 HDPE Bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 12, 2023
- Initiation Date
- Jun 26, 2023
- Termination Date
- May 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,700 HDPE Bottles
Product Description
Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08
Reason for Recall
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Distribution Pattern
Nationwide in the USA.
Code Information
Lot#: 7901903A, exp. date 04/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0895-2023
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026